Close Menu

genetic privacy

The early-stage company just launched a bioinformatics security service, but it is developing technology to label and manage individual molecules in DNA samples.

Developed by Lausanne University Hospital and presented at AMIA, the technology simulates malicious attacks on personal genomic data to risk scores for specific disclosures.

Yale University researchers have developed a file-format manipulation approach to block access to certain variants to protect participants' sensitive information.

Consumer Reports points out a regulatory gap in the US surrounding direct-to-consumer genetic tests that it says lawmakers should address.

Call to Expand

The editorial board of the Pittsburgh Post-Gazette says other lawmakers should take Florida's approach and provide additional protections against genetic discrimination.

In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.

Ruling Awaited

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.

Florida bill to bar life, disability, and long-term care insurers from using genetic information in coverage decisions poised to become law, according to Florida Politics.

Pages

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.